About
Precede develops a platform that dynamically profiles disease biology through genome-wide transcriptional analysis of cell-free DNA from blood, enabling real-time monitoring of disease mechanisms to support precision medicine and drug development.
Explore Precede's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.